Acitretin or Tazarotene Gel and Excimer Laser for Treatment of Psoriasis
A Comparison of Treatment of Psoriasis With Acitretin or Tazarotene Gel 0.1% and Active or Sham Treatments With the 308 nm Excimer Laser
Sponsor: University of Utah
Terminated
lack of efficacy and lack of funding
Other terminated trials from University of Utah
Other Psoriasis trials with similar outcome
Listed as NCT01094717, this NA trial focuses on Psoriasis and remains terminated or withdrawn. Sponsored by University of Utah, it has been updated 9 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
-
Jan 2021 — Dec 2022 [monthly]
Terminated NA
▶ Show 4 earlier versions
-
Jul 2019 — Jan 2021 [monthly]
Terminated NA
-
Jun 2018 — Jul 2019 [monthly]
Terminated NA
-
Feb 2017 — Jun 2018 [monthly]
Terminated NA
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
Jan 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Utah
For direct contact, visit the study record on ClinicalTrials.gov .